Embark Clinical Trial: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer: https://www.nejm.org/doi/full/10.1056...

Donate to PCRI: https://pcri.org/donate/
For more information, visit https://pcri.org

1:13 What is intermittent hormone therapy, and how does it work?
4:43 How is intermittent hormone therapy administered?
6:12 Is letting a patient's PSA rise to 2 advisable during therapy?
8:24 Is nine months a reasonable treatment period before considering a holiday?
9:12 How often is PSA checked during intermittent hormone therapy?
9:33 Does the type of therapy matter during intermittent hormone therapy?
11:13 Is intermittent hormone therapy complicated for insurance coverage?
12:00 How much do side effects usually recede during the holiday period?
13:45 How long can intermittent hormone therapy last?
14:45 Alex's conclusions
15:13 If you need help

Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org

To learn more about prostate cancer, visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.